Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Viemed Healthcare Q4 2024 GAAP EPS $0.10, Inline, Sales $60.70M Beat $59.95M Estimate

Author: Benzinga Newsdesk | March 10, 2025 04:03pm
Viemed Healthcare (NASDAQ:VMD) reported quarterly earnings of $0.10 per share which met the analyst consensus estimate. This is a 11.11 percent increase over earnings of $0.09 per share from the same period last year. The company reported quarterly sales of $60.70 million which beat the analyst consensus estimate of $59.95 million by 1.24 percent. This is a 19.62 percent increase over sales of $50.74 million the same period last year.

Posted In: VMD

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist